• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[人体内二肼苯哒嗪代谢物的定量鉴定]

[The quantitative identification of metabolites of dihydralazine in the human].

作者信息

Schneider T, Siegmund W, Zschiesche M, Kallwellis R, Scherber A

机构信息

Institut für Klinische Pharmakologie, Ernst-Moritz-Arndt-Universität Greifswald.

出版信息

Pharmazie. 1988 Jan;43(1):33-6.

PMID:3375299
Abstract

The metabolism of dihydralazine sulfate was studied in 11 hypertonic patients treated with that drug chronically. The metabolites were identified in urine with gc, dc, and hplc by comparison with synthesized reference compounds. Following metabolites could be verified: acetylated products, oxidation products, hydrazones and products of decomposition. Products resulting from reaction with nitrites could be not detected.

摘要

对11例长期使用硫酸双肼屈嗪治疗的高血压患者的药物代谢情况进行了研究。通过与合成的参考化合物比较,利用气相色谱(GC)、薄层色谱(DC)和高效液相色谱(HPLC)对尿液中的代谢产物进行了鉴定。可确认以下代谢产物:乙酰化产物、氧化产物、腙和分解产物。未检测到与亚硝酸盐反应产生的产物。

相似文献

1
[The quantitative identification of metabolites of dihydralazine in the human].[人体内二肼苯哒嗪代谢物的定量鉴定]
Pharmazie. 1988 Jan;43(1):33-6.
2
[The quantitative determination of dihydralazine and selected metabolites in man].[人体中肼屈嗪及其选定代谢物的定量测定]
Pharmazie. 1988 Oct;43(10):704-6.
3
The influence of the acetylator phenotype for the clinical use of dihydralazine.
Int J Clin Pharmacol Ther Toxicol. 1985 Apr;23 Suppl 1:S74-8.
4
Dihydralazine therapy and acetylator phenotype.
Int J Clin Pharmacol Biopharm. 1979 Mar;17(3):119-24.
5
[Kinetics of dihydralazine].[双肼屈嗪的动力学]
Farmakol Toksikol. 1982 May-Jun;45(3):105-7.
6
[Quantitative determination and kinetics of dihydralazine in hypertension patients].[高血压患者中二氢肼屈嗪的定量测定及动力学研究]
Pharmazie. 1985 Nov;40(11):779-81.
7
[Blood pressure effects of selected dihydralazine metabolites].
Pharmazie. 1986 Jun;41(6):439.
8
Interactions of dihydralazine with furosemide in hypertonic patients.肼屈嗪与呋塞米在高血压患者中的相互作用。
Int J Clin Pharmacol Ther Toxicol. 1987 Mar;25(3):148-51.
9
[Biotransformation in patients following Depressan-induced hepatitis].[地普西兰诱导的肝炎患者的生物转化]
Gastroenterol J. 1989;49(1):8-11.
10
[Study of the effects on coronary circulation and myocardial metabolism of a single intravenous dose of dihydralazine in 10 cases of primary myocardiopathy].[单次静脉注射双肼屈嗪对10例原发性心肌病患者冠脉循环及心肌代谢影响的研究]
Arch Mal Coeur Vaiss. 1980 Apr;73(4):413-7.

引用本文的文献

1
Drug-induced immunotoxicity.药物诱导的免疫毒性。
Eur J Drug Metab Pharmacokinet. 1998 Oct-Dec;23(4):443-51. doi: 10.1007/BF03189993.
2
Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.抗肝内质网自身抗体针对人细胞色素P - 450IA2。是肼屈嗪诱导性肝炎的特异性标志物。
J Clin Invest. 1990 Jun;85(6):1967-73. doi: 10.1172/JCI114660.